These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. An update on the malignant hyperthermia syndrome. Rosenberg H; Fletcher JE Ann Acad Med Singap; 1994 Nov; 23(6 Suppl):84-97. PubMed ID: 7710242 [TBL] [Abstract][Full Text] [Related]
6. Evaluation for malignant hyperthermia susceptibility in black-tailed deer. Antognini JF; Eisele PH; Gronert GA J Wildl Dis; 1996 Oct; 32(4):678-81. PubMed ID: 9359070 [TBL] [Abstract][Full Text] [Related]
7. Fluoroquinolones influence the intracellular calcium handling in individuals susceptible to malignant hyperthermia. Metterlein T; Schuster F; Tadda L; Hager M; Muldoon S; Capacchione J; Roewer N; Anetseder M Muscle Nerve; 2011 Aug; 44(2):208-12. PubMed ID: 21607983 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of greyhound susceptibility to malignant hyperthermia using halothane-succinylcholine anesthesia and caffeine-halothane muscle contractures. Cosgrove SB; Eisele PH; Martucci RW; Gronert GA Lab Anim Sci; 1992 Oct; 42(5):482-5. PubMed ID: 1460848 [TBL] [Abstract][Full Text] [Related]
9. Estimate of the relative risk of succinylcholine for triggering malignant hyperthermia. Dexter F; Epstein RH; Wachtel RE; Rosenberg H Anesth Analg; 2013 Jan; 116(1):118-22. PubMed ID: 23223104 [TBL] [Abstract][Full Text] [Related]
10. Case of leptosuccin induced malignant hyperthermia in a patient with GIST of the rectum. Natasa N; Snezana P; Nemanja Z; Zoran K; Durasić L Acta Chir Iugosl; 2012; 59(2):121-3. PubMed ID: 23373371 [TBL] [Abstract][Full Text] [Related]
12. [Site of action of muscle relaxants. Aspects of the transmission at the level of the neuromuscular junction]. Galindo A Rev Bras Anestesiol; 1971; 21(3):296-301. PubMed ID: 4333103 [No Abstract] [Full Text] [Related]
13. Are fade and sustained post-tetanic facilitation characteristics of typical succinylcholine-induced block? Naguib M Br J Anaesth; 2001 Sep; 87(3):522-4. PubMed ID: 11556294 [No Abstract] [Full Text] [Related]
14. [The effect of muscle relaxants on masseter tone. An experimental study in an MH-susceptible swine model]. Jantzen JP; Eberle B; Gaida BJ; Hennes HJ; Otto S; Schäfer M Anaesthesist; 1992; 41(5):248-53. PubMed ID: 1616114 [TBL] [Abstract][Full Text] [Related]
15. Malignant hyperthermia phenotype: hypotension induced by succinylcholine in susceptible swine. Sigg DC; Iaizzo PA Anesthesiology; 2000 Jun; 92(6):1777-88. PubMed ID: 10839930 [TBL] [Abstract][Full Text] [Related]
16. Malignant hyperthermia: a case report in Thai Anesthesia Incidents Study (THAI Study). Pulnitiporn A; Charuluxananan S; Inphum P; Kitsampanwong W J Med Assoc Thai; 2005 Nov; 88 Suppl 7():S149-52. PubMed ID: 16862689 [TBL] [Abstract][Full Text] [Related]
17. Different onset times of succinylcholine-induced neuromuscular blockade at the adductor pollicis and stapedius muscles. Bissinger U Anesth Analg; 1995 Dec; 81(6):1318. PubMed ID: 7486138 [No Abstract] [Full Text] [Related]
18. [Results of the association of depolarizing and non-depolarizing muscle relaxants]. Foldes FF Anesth Analg (Paris); 1971; 28(5):859-69. PubMed ID: 4258297 [No Abstract] [Full Text] [Related]
19. Multiple interacting gene products may influence susceptibility to malignant hyperthermia. Robinson RL; Curran JL; Ellis FR; Halsall PJ; Hall WJ; Hopkins PM; Iles DE; West SP; Shaw MA Ann Hum Genet; 2000 Jul; 64(Pt 4):307-20. PubMed ID: 11415515 [TBL] [Abstract][Full Text] [Related]